1Rasha M. Kamil, 2Majid. A.Z. Albadry, 3Intidhar I. Yaseen, 4Ali A. Al-fahham
1Department of Basic Science, College of Dentistry, Mustansiriah University, Baghdad, Iraq
2Education directorate of Thi-Qar, Ministry of Education, Iraq
3Directorate of Education of /Baghdadd Kark3, Ministry of Education, Iraq
4Corresponding Author, Faculty of Nursing, University of Kufa, Iraq
ABSTRACT:
The liver exerts critical functions in metabolic reactions, nutrition, detoxifying toxins, and excretion of wastes from the body. Aminotransferase are: There are two enzymes that are involved in the metabolism of amino acids: ALT and AST. The presence of them is indicative of damage to liver cells. High levels of transaminases can aid health care providers to diagnose frequent and risky hepatic disease. Both nonalcoholic and alcoholic hepatic diseases are the most well-known etiologic factors of high transaminase levels. ALT is made up of 496 amino acids. It can be detected at low levels in serum, and in high levels in the liver. Several health problems can result in increased ALT concentrations, including: celiac disease, some muscle disorders, thyroid disorders, hereditary hemochromatosis, heart failure, hepatitis, obesity, alcohol consumption, acetaminophen, nonalcoholic fatty liver disease. AST is made up of two typical dimers. It is a good indicator of human health and are of great clinical importance. High AST concentrations are frequently associated to septic shock, acute myocardial infarction, drug toxicity, cholestatic syndromes, cirrhosis, alcoholic liver disease, inflammatory liver disease (viral hepatitis), exercise, thyroid disease, myopathy, hemolysis and skeletal muscle injury.
REFERENCES :
1) Lala V, Zubair M, Minter DA. Liver Function Tests. [Updated 2023 Jul 30]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482489/
2) Oh, R. C., Hustead, T. R., Ali, S. M., & Pantsari, M. W. (2017). Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. American family physician, 96(11), 709–715.
3) Ruhl, C. E., & Everhart, J. E. (2010). Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology, 138(4), 1346–1356.e13563. https://doi.org/10.1053/j.gastro.2009.12.053
4) Yang, R. Z., Park, S., Reagan, W. J., Goldstein, R., Zhong, S., Lawton, M., Rajamohan, F., Qian, K., Liu, L., & Gong, D. W. (2009). Alanine aminotransferase isoenzymes: molecular cloning and quantitative analysis of tissue expression in rats and serum elevation in liver toxicity. Hepatology (Baltimore, Md.), 49(2), 598–607. https://doi.org/10.1002/hep.22657
5) Ozer, J., Ratner, M., Shaw, M., Bailey, W., & Schomaker, S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology, 245(3), 194–205.
https://doi.org/10.1016/j.tox.2007.11.021
6) Sinn, D. H., Kang, D., Guallar, E., Hong, Y. S., Cho, J., & Gwak, G. Y. (2022). Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels: a nationwide cohort study. BMC medicine, 20(1), 18. https://doi.org/10.1186/s12916-021-02215-x
7) Moriles, K. E., Zubair, M., & Azer, S. A. (2024). Alanine Aminotransferase (ALT) Test. In StatPearls. StatPearls Publishing.
8) Ioannou, G. N., Weiss, N. S., Boyko, E. J., Mozaffarian, D., & Lee, S. P. (2006). Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology (Baltimore, Md.), 43(5), 1145–1151.
https://doi.org/10.1002/hep.21171
9) Zheng, J. R., Wang, Z. L., Jiang, S. Z., Chen, H. S., & Feng, B. (2023). Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World journal of hepatology, 15(6), 813–825. https://doi.org/10.4254/wjh.v15.i6.813
10) Qiu, J., Kuang, M., Yang, R., Yu, C., He, S., Sheng, G., & Zou, Y. (2023). The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease. Frontiers in endocrinology, 14, 1239398. https://doi.org/10.3389/fendo.2023.1239398
11) Aloisio, E., Colombo, G., Arrigo, C., Dolci, A., & Panteghini, M. (2021). Sources and clinical significance of aspartate aminotransferase increases in COVID-19. Clinica chimica acta; international journal of clinical chemistry, 522, 88–95. https://doi.org/10.1016/j.cca.2021.08.012
12) Panteghini M. (1990). Aspartate aminotransferase isoenzymes. Clinical biochemistry, 23(4), 311–319. https://doi.org/10.1016/0009-9120(90)80062-n
13) Huang, X. J., Choi, Y. K., Im, H. S., Yarimaga, O., Yoon, E., & Kim, H. S. (2006). Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques. Sensors (Basel, Switzerland), 6(7), 756–782.
14) Toney M. D. (2014). Aspartate aminotransferase: an old dog teaches new tricks. Archives of biochemistry and biophysics, 544, 119–127.
https://doi.org/10.1016/j.abb.2013.10.002
15) Ndrepepa G. (2021) Aspartate aminotransferase and cardiovascular disease—a narrative review. J Lab Precis Med;6:6. Doi.10.21037/jlpm-20-93
16) Murao, N., Yokoi, N., Honda, K., Han, G., Hayami, T., Gheni, G., Takahashi, H., Minami, K., & Seino, S. (2017). Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in β-cell glutamate signaling for incretin-induced insulin secretion. PloS one, 12(11), e0187213. https://doi.org/10.1371/journal.pone.0187213
17) Josekutty, J., Iqbal, J., Iwawaki, T., Kohno, K., & Hussain, M. M. (2013). Microsomal triglyceride transfer protein inhibition induces endoplasmic reticulum stress and increases gene transcription via Ire1α/cJun to enhance plasma ALT/AST. The Journal of biological chemistry, 288(20), 14372–14383. https://doi.org/10.1074/jbc.M113.459602
18) Ioannou, G. N., Boyko, E. J., & Lee, S. P. (2006). The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. The American journal of gastroenterology, 101(1), 76–82. https://doi.org/10.1111/j.1572-0241.2005.00341.x
19) Parisi, I., O’Beirne, J., Rossi, R. E., Tsochatzis, E., Manousou, P., Theocharidou, E., Hamilton, M., Murray, C., Epstein, O., & Burroughs, A. K. (2016). Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab. European journal of gastroenterology & hepatology, 28(7), 786–791.
https://doi.org/10.1097/MEG.0000000000000624
20) Oh, J. S., Choi, J. S., Lee, Y. H., Ko, K. O., Lim, J. W., Cheon, E. J., Lee, G. M., & Yoon, J. M. (2016). The Relationships between Respiratory Virus Infection and Aminotransferase in Children. Pediatric gastroenterology, hepatology & nutrition, 19(4), 243–250. https://doi.org/10.5223/pghn.2016.19.4.243